News Daily News AHA Provides Guidance on Drug-Drug Interactions With Statins and CVD Medications Michael O'Riordan October 18, 2016
News Daily News Use of Evidence-Based Medical Therapy Steadily Improving in Acute MI Patients Postdischarge Michael O'Riordan September 30, 2016
News Conference News ESC 2016 Long-term Exposure to Lower LDL Cholesterol, Blood Pressure Has Potential to Dramatically Cut CV Risk Todd Neale August 29, 2016
News Daily News MI Patients Who Develop Heart Failure Vulnerable to Higher Risk of Cancer Michael H. Wilson July 13, 2016
News Daily News With Greater Uptake, ARNIs Could Potentially Save the Lives of Nearly 30,000 Patients Each Year Michael H. Wilson June 28, 2016
News Daily News When Industry Pays for Meals, Physicians Are More Likely to Prescribe Certain Brand-name Drugs Caitlin E. Cox June 22, 2016
News Daily News US and European Heart Failure Guidelines Advocate Use of Two New Therapies L.A. McKeown May 24, 2016
News Daily News Could Biased Medication Prescribing Explain Obesity Paradox in PCI? L.A. McKeown May 19, 2016
News Conference News ACC 2016 HOPE-3: Reducing LDL Cholesterol Improves Outcomes in Intermediate-Risk Patients, but BP-Lowering Does Not Michael O'Riordan April 02, 2016
News Daily News Calculator Developed to Predict AKI Risk After Angiography in VA Population Caitlin E. Cox December 29, 2015
News Conference News AHA 2015 SPRINT Makes Case for Even Lower BP Target in Many Hypertensive Patients Todd Neale November 08, 2015
News Daily News Revascularization May Benefit Stable CAD Patients With Unclassifiable Appropriateness Scores Todd Neale October 08, 2015
News Conference News ESC 2015 High-Sensitivity Troponin Assay Use Does Not Appear to Increase Diagnostic Procedures L.A. McKeown September 02, 2015
News Industry News Bayer Expands Finerenone Clinical Development Program with Three Phase III Studies for Finerenone in Patients with Diabetic Kidney Disease and Patients with Chronic Heart Failure August 31, 2015
News Daily News Cardiac Rehab After Acute MI Linked to Improved Survival, Medication Adherence Leah Lawrence August 30, 2015
News Daily News International Study Links Treatment Variations to Mortality in Acute MI Yael L. Maxwell August 14, 2015
News Daily News FDA Approves Heart Failure Drug That Comes With Survival Benefit Todd Neale July 13, 2015
News Industry News Novartis' new heart failure medicine LCZ696 approved by FDA to reduce risk of cardiovascular death and heart failure hospitalization; now called Entresto™ (sacubitril-valsartan) July 07, 2015